Group One Trading’s Marker Therapeutics MRKR Stock Holding History

Group One Trading’s Portfolio MRKR Stock Details MRKR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$262	Hold	178	–	–	﹤0.01%	7360
2026 Q1	$231	Hold	178	–	–	﹤0.01%	7387
2025 Q4	$265	Hold	178	–	–	﹤0.01%	7864
2025 Q3	$159	Hold	178	–	–	﹤0.01%	8225
2025 Q2	$272	Hold	178	–	–	﹤0.01%	7718
2025 Q1	$219	Hold	178	–	–	﹤0.01%	7368
2024 Q4	$554	Hold	178	–	–	﹤0.01%	6993
2024 Q3	$502	Hold	178	–	–	﹤0.01%	6391
2024 Q2	$967	Hold	178	–	–	﹤0.01%	6368
2024 Q1	$765	Hold	178	–	–	﹤0.01%	6686
2023 Q4	$979	Hold	178	–	–	﹤0.01%	6989
2023 Q3	$819	Hold	178	–	–	﹤0.01%	7252
2023 Q2	$552	Hold	178	–	–	﹤0.01%	7354
2023 Q1	$126	Sell	178 -111	-38%	-$264	﹤0.01%	7022
2022 Q4	$761	Sell	289 -237	-45%	-$818	﹤0.01%	6892
2022 Q3	$2K	Buy	526 +210	+66%	+$771	﹤0.01%	7170
2022 Q2	$1K	Sell	316 -2,727	-90%	-$9.07K	﹤0.01%	7584
2022 Q1	$13K	Buy	3,043 +158	+5%	+$903	﹤0.01%	7054
2021 Q4	$27K	Buy	+2,885	New	+$38.3K	﹤0.01%	6786
2020 Q2	–	Sell	-76	Closed	-$1.66K	–	6031
2020 Q1	$1K	Sell	76 -505	-87%	-$12.9K	﹤0.01%	5087
2019 Q4	$17K	Sell	581 -790	-58%	-$28.7K	﹤0.01%	4418
2019 Q3	$70K	Buy	1,371 +618	+82%	+$36.5K	﹤0.01%	3800
2019 Q2	$60K	Buy	+753	New	+$44.7K	﹤0.01%	3676

Other funds holding MRKR

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACM

Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

CIA

Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return

Group One Trading's MRKR Position: Q2 2026 in Review

Group One Trading held its Marker Therapeutics (MRKR) position steady in Q2 2026 at 178 shares worth $262. The position accounts for ﹤0.01% of the portfolio, ranked #7360.

Group One Trading first reported a position in MRKR in Q2 2019 and has held it in 23 quarters since. The position peaked at $70K in Q3 2019. 35 funds tracked by Wall St. Rank hold MRKR as of Q2 2026.

Group One Trading held 178 shares of Marker Therapeutics worth $262 as of Q2 2026.
Group One Trading left its Marker Therapeutics share count unchanged in Q2 2026.
Marker Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #7360 holding.
Group One Trading first reported a position in Marker Therapeutics in Q2 2019 and has held it in 23 quarters since.
Group One Trading's Marker Therapeutics position peaked at $70K in Q3 2019.
35 funds tracked by Wall St. Rank held Marker Therapeutics as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.